Hostname: page-component-76fb5796d-vfjqv Total loading time: 0 Render date: 2024-04-28T12:20:20.223Z Has data issue: false hasContentIssue false

The effect of atrial septostomy on the concentration of brain-type natriuretic peptide in patients with idiopathic pulmonary arterial hypertension

Published online by Cambridge University Press:  01 October 2007

Michael L O’Byrne
Affiliation:
Columbia University College of Physicians and Surgeons New York, New York, USA
Erika S Berman Rosenzweig
Affiliation:
Columbia University College of Physicians and Surgeons New York, New York, USA
Robyn J Barst*
Affiliation:
Columbia University College of Physicians and Surgeons New York, New York, USA
*
Correspondence to: Robyn J Barst, MD, New York Presbyterian Pulmonary Hypertension Center, Morgan Stanley Children’s Hospital of New York, 3959 Broadway BHN 2-262, New York, NY 10032, USA. Tel: (212) 305-4436; Fax: (212) 342-1443; E-mail: rjb3@columbia.edu

Abstract

Atrial septostomy has improved haemodynamics and clinical symptoms in selected patients with idiopathic pulmonary arterial hypertension. We found that, in 5 patients with idiopathic pulmonary arterial hypertension, septostomy resulted in decreased levels of brain-type natriuretic peptide, and improvement in symptoms of cardiac failure, suggesting that serial measurements of the peptide may have clinical utility.

Type
Brief Report
Copyright
Copyright © Cambridge University Press 2007

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Rozkovec, A, Montanes, P, Oakley, CM. Factors that influence the outcome of primary pulmonary hypertension. BMJ 1986; 55: 449458.Google ScholarPubMed
2.Hopkins, WE, Ochoa, LL, Richardson, GW, Trulock, EP. Comparison of the hemodynamics and survival of adults with severe primary pulmonary hypertension or Eisenmenger syndrome. J Heart Lung Transplant 1996; 15: 100105.Google ScholarPubMed
3.Rich, S, Dodin, E, McLaughlin, VV. Usefulness of atrial septostomy as a treatment for primary pulmonary hypertension and guidelines for its application. Am J Cardiol 1997; 80: 369371.CrossRefGoogle ScholarPubMed
4.Reichenberger, F, Pepke-Zaba, J, McNeil, K, Parameshwar, J, Shapiro, LM. Atrial septostomy in the treatment of severe pulmonary arterial hypertension. Thorax 2003; 58: 797800.CrossRefGoogle ScholarPubMed
5.Nihill, MR, O’Laughlin, MP, Mullins, CE. Effects of atrial septostomy in patients with terminal cor pulmonale due to pulmonary vascular disease. Cathet Cardiovasc Diag 1991; 24: 166172.CrossRefGoogle ScholarPubMed
6.Sandoval, J, Gaspar, J, Pulido, T, et al. . Graded balloon dilation atrial septostomy in severe primary pulmonary hypertension. A therapeutic alternative for patients nonresponsive to vasodilator treatment. J Am Coll Cardiol 1998; 32: 297304.Google ScholarPubMed
7.Rothman, A, Sklansky, MS, Lucas, VW, et al. . Atrial septostomy as a bridge to lung transplantation in patients with severe pulmonary hypertension. Am J Cardiol 1999; 84: 682686.CrossRefGoogle ScholarPubMed
8.Thanopoulos, BD, Georgakopoulos, D, Tsaousis, GS, Simeunovic, S. Percutaneous balloon dilatation of the atrial septum: immediate and midterm results. Heart 1996; 76: 502506.CrossRefGoogle ScholarPubMed
9.Kerstein, D, Levy, PS, Hsu, DT, Hordof, AJ, Gersony, WM, Barst, RJ. Blade balloon atrial septostomy in patients with severe primary pulmonary hypertension. Circulation 1995; 91: 20282035.CrossRefGoogle ScholarPubMed
10.Micheletti, A, Hislop, AA, Lammers, A, et al. . Role of atrial septostomy in the treatment of children with pulmonary arterial hypertension. Heart 2006; 92: 969972.CrossRefGoogle ScholarPubMed